Preoperative NSAID to Colorectal Cancer Patients - Tabular View

Home

Study Topics

Glossary


	Full Text View


	Tabular View


	Contacts and Locations


	Related Studies

Preoperative NSAID to Colorectal Cancer Patients

This study has been completed.
Information provided by Göteborg University

This Tabular View shows the required WHO registration data elements as marked by ^†

Descriptive Information Fields

Brief Title ^†

Preoperative NSAID to Colorectal Cancer Patients

Official Title ^†

Preoperative Treatment With NSAID in Colorectal Cancer Patients in Relationship to Tumor Host Reactions

Brief Summary

The study is designed to evaluate effects of NSAIDs on immune activity inside and close to tumor tissue in patients with colorectal cancer.

Detailed Description

Study and control patients are randomized to receive preoperative treatment with indomethacin or celecoxib compared to sham treatment.Tumor biopsies are taken at operation and used for analyses of tumor immunity and gene expression.

Study Phase

Phase IV

Study Type ^†

Interventional

Study Design ^†

Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study

Primary Outcome Measure ^†

Immune reactivity [ Time Frame: Acute evaluations ]

Secondary Outcome Measure ^†

Condition ^†

Colorectal Cancer

Intervention ^†

Drug: Indomethacin, celecoxib, esomeprazole

MEDLINE PMIDs

Links

Göteborg University This link exits the ClinicalTrials.gov site

Recruitment Information Fields

Recruitment Status ^†

Completed

Enrollment ^†

Start Date ^†

December 1998

Completion Date

May 2007

Eligibility Criteria ^†

Inclusion Criteria:

Colon carcinoma scheduled for curative operation

Exclusion Criteria:

Diabetes, steroid medication, liver and kidney impairment

Gender

Both

Ages

40 Years to 80 Years

Accepts Healthy Volunteers

Contacts ^††

Location Countries ^†

Sweden

Administrative Information Fields

NCT ID ^†

NCT00473980

Organization ID

kl4501122

Secondary IDs ^††

Study Sponsor ^†

Göteborg University

Collaborators ^††

Investigators ^†

Principal Investigator:

Kent Lundholm, MD, prof

Göteborg University

Information Provided By

Göteborg University

Verification Date

May 2007

First Received Date ^†

May 15, 2007

Last Updated Date

May 15, 2007

^† Required WHO trial registration data element.
^†† WHO trial registration data element that is required only if it exists.